Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate

Bioorganic & Medicinal Chemistry Letters
2021.0

Abstract

The enzyme 2-methylerythritol 2,4-cyclodiphosphate synthase, IspF, is essential for the biosynthesis of isoprenoids in most bacteria, some eukaryotic parasites, and the plastids of plant cells. The development of inhibitors that target IspF may lead to novel classes of anti-infective agents or herbicides. Enantiomers of tryptophan hydroxamate were synthesized and evaluated for binding to Burkholderia pseudomallei (Bp) IspF. The L-isomer possessed the highest potency, binding BpIspF with a K<sub>D</sub> of 36 µM and inhibited BpIspF activity 55% at 120 µM. The high-resolution crystal structure of the L-tryptophan hydroxamate (3)/BpIspF complex revealed a non-traditional mode of hydroxamate binding where the ligand interacts with the active site zinc ion through the primary amine. In addition, two hydrogen bonds are formed with active site groups, and the indole group is buried within the hydrophobic pocket composed of side chains from the 60 s/70 s loop. Along with the co-crystal structure, STD NMR studies suggest the methylene group and indole ring are potential positions for optimization to enhance binding potency.

Knowledge Graph

Similar Paper

Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate
Bioorganic &amp; Medicinal Chemistry Letters 2021.0
Antibacterial activity of 2-amino-4-hydroxypyrimidine-5-carboxylates and binding to Burkholderia pseudomallei 2-C-methyl-d-erythritol-2,4-cyclodiphosphate synthase
Bioorganic &amp; Medicinal Chemistry Letters 2019.0
Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei
Bioorganic &amp; Medicinal Chemistry Letters 2013.0
A Structure-Based Approach to Ligand Discovery for 2C-Methyl-<scp>d</scp>-erythritol-2,4-cyclodiphosphate Synthase: A Target for Antimicrobial Therapy
Journal of Medicinal Chemistry 2009.0
Reverse Fosmidomycin Derivatives against the Antimalarial Drug Target IspC (Dxr)
Journal of Medicinal Chemistry 2011.0
Synthesis and biological evaluation of pyrazolopyrimidines as potential antibacterial agents
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
Inhibition of the Fe<sub>4</sub>S<sub>4</sub>-Cluster-Containing Protein IspH (LytB): Electron Paramagnetic Resonance, Metallacycles, and Mechanisms
Journal of the American Chemical Society 2010.0
Synthesis and theoretic calculations of benzoxazoles and docking studies of their interactions with triosephosphate isomerase
Medicinal Chemistry Research 2013.0
In search of new herbicidal inhibitors of the non‐mevalonate pathway
Pest Management Science 2013.0
Synthesis and Bioactivity of β-Substituted Fosmidomycin Analogues Targeting 1-Deoxy-<scp>d</scp>-xylulose-5-phosphate Reductoisomerase
Journal of Medicinal Chemistry 2015.0